查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1808843

非侵入性產前檢測市場，依檢測類型、技術、應用、最終用戶、國家及地區分類－2025 年至 2032 年全球產業分析、市場規模、市場佔有率及預測

Non-invasive Prenatal Testing Market, By Test Type, By Technology, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年非侵入性產前檢測市場規模價值 72.1029 億美元，2025 年至 2032 年的複合年成長率為 14.41%。

非侵入性產前檢測 (NIPT) 是一種篩檢技術，可透過檢測孕婦血液中的胎兒 DNA 來識別唐氏症、愛德華茲氏症候群和帕陶氏症候群等染色體異常。它提供了一種比羊膜穿刺術和絨毛取樣等侵入性方法更安全的替代方案，從而降低了母嬰的風險。隨著人們對遺傳疾病認知的不斷提高、測序技術的進步以及對早期準確胎兒健康評估的需求不斷成長，NIPT 的應用也得到了推動。

產前護理基礎設施的改善以及對個人化醫療日益成長的重視，進一步推動了市場的發展。越來越多的醫護人員和準父母選擇NIPT，因為它精準、便利且非侵入性。此外，NIPT與綜合產前篩檢計畫的整合，也擴大了其臨床應用範圍。然而，倫理問題和監管框架持續影響市場趨勢。全球高危險妊娠的增加也推動了需求，促使檢測技術持續創新。

非侵入性產前檢測市場-市場動態

對安全、早期和準確的胎兒基因篩檢測試的需求不斷成長。

準媽媽們對非侵入性、低風險產前檢測的日益青睞，顯著提升了對非侵入性產前檢測 (NIPT) 的需求，從而推動了市場成長。根據美國婦產科醫師學會 (ACOG) 的數據，傳統的侵入性檢測（例如羊膜穿刺術和絨毛取樣）的流產風險約為 0.1-0.3%，而 NIPT 則透過簡單的孕婦抽血，提供了更安全的替代方法。

NIPT 能夠早期準確地檢測出染色體異常，例如 21 三體症候群（唐氏症）、18 三體症（愛德華茲氏症候群）和 13 三體症（帕陶氏症候群），通常最早可在懷孕第 10 週發現。研究表明，NIPT 對唐氏症的檢測敏感度和特異性均超過 99%，大大增強了檢測結果的可信度。無細胞胎兒 DNA 分析技術的不斷進步，提高了敏感度和特異性，使 NIPT 成為值得信賴的早期篩檢方案。越來越多的醫療保健提供者推薦 NIPT 作為更安全的產前護理方案的一部分。

非侵入性產前檢測市場－關鍵洞察

根據我們的研究分析師的分析，預測期內（2025-2032 年）全球市場預計年複合成長率約為 14.41%

根據測試類型細分，基於定序的 NIPT 預計將在 2024 年佔據最大市場佔有率

根據技術細分，次世代定序 (NGS) 是 2024 年的領先技術

根據應用細分，唐氏症篩檢是 2024 年領先的應用

按地區分類，北美是 2024 年的主要收入來源

非侵入性產前檢測市場-細分分析：

全球無創產前檢測市場根據檢測類型、技術、應用、最終用戶和地區進行細分。

根據檢測類型，市場分為三類：基於定序的NIPT、基於微陣列的NIPT和基於PCR的NIPT。基於定序的NIPT因其高準確性和廣泛的檢測能力而佔據主導地位。此方法利用新一代定序技術分析遊離胎兒DNA，可同時檢測多種染色體異常。與PCR或微陣列方法相比，基於終端使用者的定序方法靈敏度更高，甚至可以檢測到母體血液中含量較低的胎兒DNA。

這種綜合方法吸引了尋求可靠、多條件產前篩檢的醫療保健提供者。定序通量的持續提升和成本的降低增強了其可及性和應用性。整合生物資訊學工具的能力進一步增強了臨床解讀。因此，基於定序的檢測通常是常規NIPT的首選，這使得該領域成為市場領導者。

根據技術，市場可分為四大類：新一代定序 (NGS)、聚合酶鍊式反應 (PCR)、微陣列和其他。在非侵入性產前檢測 (NIPT) 市場中，按技術分類的最主要細分領域是新一代定序 (NGS)。 NGS 能夠對母體血液中的胎兒 DNA 進行高度準確和全面的分析，徹底改變了產前篩檢領域。它能夠檢測多種基因異常，包括常見的三體症候群（例如 21、18 和 13 三體症候群）、微缺失和性染色體非整倍體，這使其成為臨床醫生和診斷實驗室的首選技術。

與傳統方法不同，NGS 具有更高的靈敏度和特異性，減少了對羊膜穿刺等侵入性確認檢測的需求。其可擴展性、通量和成本效益進一步提升了其應用，尤其是在擁有先進醫療基礎設施的已開發國家。 Illumina、Roche 和 Natera 等大型診斷公司利用 NGS 平台提供 NIPT 解決方案，持續推動創新。

非侵入性產前檢測市場—地理洞察

北美仍然是非侵入性產前檢測 (NIPT) 的領先市場，這得益於其先進的醫療基礎設施和早期採用的基因篩檢技術。美國在該區域市場佔據主導地位，這得益於產前健康意識的不斷提升、大量需要篩檢的孕婦以及完善的監管框架簡化了產品核准流程。越來越多的醫療機構將 NIPT 納入常規產前護理，這得益於醫療指南和宣傳活動，這些活動旨在促進 NIPT 的普及。

美國也是NIPT的創新中心，擁有許多重要的產業參與者和研究機構。新一代定序和高效能實驗室系統的日益普及顯著縮短了檢測週期，使檢測更加便捷。隨著產科醫師不僅推薦高風險孕婦進行NIPT，也建議中度風險孕婦進行NIPT，NIPT的需求持續成長。

非侵入性產前檢測市場-競爭格局：

非侵入性產前檢測市場的競爭格局體現在快速的技術進步、強勁的研發投入以及主要參與者之間的策略合作。各公司正致力於擴展其檢測範圍，以涵蓋更廣泛的遺傳疾病。定序終端用戶和生物資訊學的創新提高了檢測準確性，並縮短了周轉時間，從而帶來了競爭優勢。

與醫療保健提供者和付款人的合作有助於提高市場滲透率和保險報銷。一些參與者正在尋求向新興市場擴張，以擴大客戶群。競爭性定價和客製化的檢測解決方案也發揮著重要作用。此外，法規合規性和資料隱私考量也是關鍵的競爭因素。合併、收購和合作進一步加劇了市場競爭。公司也投資於教育項目，以提高人們對NIPT益處的認知。

最新動態：

2025 年 5 月，Natera, Inc. 宣布推出新的擴展 NIPT 面板，針對更多罕見遺傳疾病，以增強產前篩檢能力。

2025年4月，Illumina公司推出了基於雲端的定序平台軟體升級，提高了NIPT資料分析的速度和準確性。

目錄

第1章：非侵入性產前檢測市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 非侵入性產前檢測市場片段（依檢測類型）
    • 非侵入性產前檢測市場（依技術）
    • 非侵入性產前檢測市場片段（按應用）
    • 非侵入性產前檢測市場片段（按最終用戶）
    • 各國無創產前檢測市場概況
    • 非侵入性產前檢測市場（按地區）
  • 競爭洞察

第3章：非侵入性產前檢測主要市場趨勢

  • 非侵入性產前檢測市場促進因素
    • 市場促進因素的影響分析
  • 非侵入性產前檢測市場限制
    • 市場限制的影響分析
  • 無創產前檢測市場機會
  • 非侵入性產前檢測市場未來趨勢

第4章：非侵入性產前檢測產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：非創產前檢測市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：非侵入性產前檢測市場格局

  • 2024年非侵入性產前檢測市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：非侵入性產前檢測市場－依檢測類型

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 基於定序的NIPT
    • 基於微陣列的NIPT
    • 基於PCR的NIPT

第 8 章：非侵入性產前檢測市場 - 按技術

  • 概述
    • 按技術細分的市場佔有率分析
    • 下一代定序（NGS）
    • 聚合酶鍊式反應（PCR）
    • 微陣列
    • 其他

第9章：非侵入性產前檢測市場－按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 唐氏症篩檢
    • 愛德華茲症候群篩檢
    • 帕陶症候群篩檢
    • 性染色體非整倍體篩檢
    • 其他

第 10 章：非侵入性產前檢測市場 - 按最終用戶

  • 概述
    • 按技術細分的市場佔有率分析
    • 醫院和診所
    • 診斷實驗室
    • 研究機構

第 11 章：非侵入性產前檢測市場-按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美無創產前檢測主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按測試類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按應用）
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲無創產前檢測主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模和預測（按測試類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區無創產前檢測主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依測試類型）
    • 亞太地區市場規模及預測（依技術）
    • 亞太地區市場規模及預測（按應用）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲無創產前檢測主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按測試類型）
    • 拉丁美洲市場規模及預測（按技術）
    • 拉丁美洲市場規模及預測（按應用）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲無創產前檢測主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依測試類型）
    • MEA 市場規模及預測（依技術）
    • MEA 市場規模及預測（按應用）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 12 章：主要供應商分析-非侵入性產前檢測產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Illumina, Inc.
    • Roche Diagnostics
    • BGI Genomics
    • Myriad Genetics, Inc.
    • Natera, Inc.
    • PerkinElmer, Inc.
    • Invitae Corporation
    • Thermo Fisher Scientific, Inc.
    • Laboratory Corporation of America Holdings (LabCorp)
    • QIAGEN NV
    • Berry Genomics Co., Ltd.
    • Agilent Technologies, Inc.
    • Eurofins Scientific
    • Fulgent Genetics
    • Genesis Genomics
    • GeneDx, Inc.
    • CooperGenomics
    • Congenica
    • GenePlanet
    • Integrated Genetics

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5492

Non-invasive Prenatal Testing Market size was valued at US$ 7,210.29 Million in 2024, expanding at a CAGR of 14.41% from 2025 to 2032.

Non-invasive prenatal testing (NIPT) is a screening technique that examines fetal DNA in a pregnant woman's bloodstream to identify chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome. It offers a safer alternative to invasive methods like amniocentesis and chorionic villus sampling, reducing risks for both mother and baby. The adoption of NIPT is being fueled by growing awareness of genetic conditions, advancements in sequencing technologies, and the rising demand for early and accurate fetal health assessments.

The market is further supported by improved prenatal care infrastructure and the growing emphasis on personalized medicine. Both healthcare professionals and expectant parents are increasingly choosing NIPT for its precision, ease, and non-invasive approach. Additionally, the integration of NIPT with comprehensive prenatal screening panels is expanding its clinical relevance. However, ethical concerns and regulatory frameworks continue to influence market trends. The global increase in high-risk pregnancies is also driving demand, prompting continued innovation in testing technologies.

Non-invasive Prenatal Testing Market- Market Dynamics

Rising demand for safe, early, and accurate fetal genetic screening tests.

The growing preference for non-invasive and low-risk prenatal testing among expectant mothers is significantly boosting the demand for Non-Invasive Prenatal Testing (NIPT), driving market growth. In contrast to traditional invasive procedures-such as amniocentesis and chorionic villus sampling-that carry a miscarriage risk of approximately 0.1-0.3% according to the American College of Obstetricians and Gynecologists (ACOG), NIPT offers a safe alternative through a simple maternal blood draw.

NIPT enables early and accurate detection of chromosomal abnormalities, such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome), often as early as the 10th week of pregnancy. Studies have shown that NIPT has a sensitivity and specificity of over 99% for detecting Down syndrome, greatly enhancing confidence in test outcomes. Ongoing advancements in cell-free fetal DNA analysis have improved both sensitivity and specificity, making NIPT a trusted option for early screening. Healthcare providers are increasingly recommending NIPT as part of safer prenatal care protocols.

Non-invasive Prenatal Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.41% over the forecast period (2025-2032)

Based on Test Type segmentation, sequencing-based NIPT was predicted to show maximum market share in the year 2024

Based on Technology segmentation, Next-Generation Sequencing (NGS) were the leading Technology in 2024

Based on Application segmentation, Down Syndrome Screening was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Non-invasive Prenatal Testing Market- Segmentation Analysis:

The Global Non-invasive Prenatal Testing Market is segmented on the basis of Test Type, Technology, Application, End-user, and Region.

The market is divided into three categories based on Test Type: Sequencing-based NIPT, Microarray-based NIPT, and PCR-based NIPT. The sequencing-based NIPT segment dominates due to its high accuracy and broad detection capabilities. This method analyzes cell-free fetal DNA with next-generation sequencing, allowing detection of multiple chromosomal abnormalities simultaneously. Sequencing End-user provides greater sensitivity compared to PCR or microarray methods, enabling detection of even low fetal DNA fractions in maternal blood.

This comprehensive approach appeals to healthcare providers seeking reliable, multi-condition prenatal screening. Continuous improvements in sequencing throughput and cost reduction enhance its accessibility and adoption. The ability to integrate bioinformatics tools further strengthens clinical interpretation. As a result, sequencing-based tests are often preferred for routine NIPT, making this segment the market leader.

The market is divided into four categories based on Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, and Others. The most dominant segment in the Non-Invasive Prenatal Testing (NIPT) market by technology is Next-Generation Sequencing (NGS). NGS has revolutionized the field of prenatal screening by enabling highly accurate and comprehensive analysis of fetal DNA from maternal blood. Its ability to detect a wide range of genetic abnormalities, including common trisomies (such as Trisomy 21, 18, and 13), microdeletions, and sex chromosome aneuploidies, has made it the preferred technology among clinicians and diagnostic laboratories.

Unlike traditional methods, NGS offers higher sensitivity and specificity, reducing the need for invasive confirmatory tests like amniocentesis. Its scalability, throughput, and cost-efficiency have further boosted its adoption, particularly in developed countries with advanced healthcare infrastructure. Major diagnostic companies like Illumina, Roche, and Natera leverage NGS platforms for their NIPT solutions, driving continuous innovation.

Non-invasive Prenatal Testing Market- Geographical Insights

North America remains a leading market for Non-Invasive Prenatal Testing (NIPT), supported by its advanced healthcare infrastructure and early adoption of genetic screening technologies. The United States dominates the regional landscape, driven by rising awareness of prenatal health, a large volume of pregnancies requiring screening, and well-defined regulatory frameworks that streamline product approvals. A growing number of healthcare providers now include NIPT in routine prenatal care, further supported by medical guidelines and awareness initiatives that promote testing adoption.

The U.S. is also a hub for innovation in NIPT, home to several major industry players and research institutions. The increasing use of next-generation sequencing and efficient laboratory systems has significantly reduced turnaround times, making the tests more accessible. Demand continues to rise as obstetricians recommend NIPT not only for high-risk but also for average-risk pregnancies.

Non-invasive Prenatal Testing Market- Competitive Landscape:

The competitive landscape of the Non-invasive Prenatal Testing Market is characterized by rapid technological advancements, strong R&D investment, and strategic collaborations among key players. Companies are focusing on expanding their testing panels to include a broader range of genetic conditions. Innovation in sequencing End-user and bioinformatics enhances test accuracy and reduces turnaround times, offering a competitive edge.

Collaborations with healthcare providers and payers help improve market penetration and insurance reimbursement. Some players are pursuing geographic expansion to emerging markets to increase their customer base. Competitive pricing and customization of testing solutions also play important roles. Additionally, regulatory compliance and data privacy considerations are critical competitive factors. Mergers, acquisitions, and partnerships further intensify market rivalry. Companies also invest in educational initiatives to raise awareness about NIPT benefits.

Recent Developments:

In May 2025, Natera, Inc. announced a new expanded NIPT panel targeting additional rare genetic conditions to enhance prenatal screening capabilities.

In April 2025, Illumina, Inc. launched a cloud-based software upgrade for its sequencing platform, improving NIPT data analysis speed and accuracy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Illumina, Inc.
  • Roche Diagnostics
  • BGI Genomics
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • PerkinElmer, Inc.
  • Invitae Corporation
  • Thermo Fisher Scientific, Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • QIAGEN N.V.
  • Berry Genomics Co., Ltd.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • Fulgent Genetics
  • Genesis Genomics
  • GeneDx, Inc.
  • CooperGenomics
  • Congenica
  • GenePlanet
  • Integrated Genetics

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Sequencing-based NIPT
  • Microarray-based NIPT
  • PCR-based NIPT

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Others

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Down Syndrome Screening
  • Edwards Syndrome Screening
  • Patau Syndrome Screening
  • Sex Chromosome Aneuploidy Screening
  • Others

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Non-invasive Prenatal Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Non-invasive Prenatal Testing Market Snippet by Test Type
    • 2.1.2. Non-invasive Prenatal Testing Market Snippet by Technology
    • 2.1.3. Non-invasive Prenatal Testing Market Snippet by Application
    • 2.1.4. Non-invasive Prenatal Testing Market Snippet by End-user
    • 2.1.5. Non-invasive Prenatal Testing Market Snippet by Country
    • 2.1.6. Non-invasive Prenatal Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Non-invasive Prenatal Testing Key Market Trends

  • 3.1. Non-invasive Prenatal Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Non-invasive Prenatal Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Non-invasive Prenatal Testing Market Opportunities
  • 3.4. Non-invasive Prenatal Testing Market Future Trends

4. Non-invasive Prenatal Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Non-invasive Prenatal Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Non-invasive Prenatal Testing Market Landscape

  • 6.1. Non-invasive Prenatal Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Non-invasive Prenatal Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Sequencing-based NIPT
    • 7.1.3. Microarray-based NIPT
    • 7.1.4. PCR-based NIPT

8. Non-invasive Prenatal Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Next-Generation Sequencing (NGS)
    • 8.1.3. Polymerase Chain Reaction (PCR)
    • 8.1.4. Microarray
    • 8.1.5. Others

9. Non-invasive Prenatal Testing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Down Syndrome Screening
    • 9.1.3. Edwards Syndrome Screening
    • 9.1.4. Patau Syndrome Screening
    • 9.1.5. Sex Chromosome Aneuploidy Screening
    • 9.1.6. Others

10. Non-invasive Prenatal Testing Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 10.1.2. Hospitals & Clinics
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Research Institutes

11. Non-invasive Prenatal Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Non-invasive Prenatal Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Non-invasive Prenatal Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Non-invasive Prenatal Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Non-invasive Prenatal Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Non-invasive Prenatal Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Non-invasive Prenatal Testing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Illumina, Inc.
    • 12.2.2. Roche Diagnostics
    • 12.2.3. BGI Genomics
    • 12.2.4. Myriad Genetics, Inc.
    • 12.2.5. Natera, Inc.
    • 12.2.6. PerkinElmer, Inc.
    • 12.2.7. Invitae Corporation
    • 12.2.8. Thermo Fisher Scientific, Inc.
    • 12.2.9. Laboratory Corporation of America Holdings (LabCorp)
    • 12.2.10. QIAGEN N.V.
    • 12.2.11. Berry Genomics Co., Ltd.
    • 12.2.12. Agilent Technologies, Inc.
    • 12.2.13. Eurofins Scientific
    • 12.2.14. Fulgent Genetics
    • 12.2.15. Genesis Genomics
    • 12.2.16. GeneDx, Inc.
    • 12.2.17. CooperGenomics
    • 12.2.18. Congenica
    • 12.2.19. GenePlanet
    • 12.2.20. Integrated Genetics

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us